rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
4
|
pubmed:dateCreated |
2001-9-10
|
pubmed:abstractText |
We studied phospholipid composition of high-density lipoproteins in patients with normo- and hypertriglyceridemia treated with various hypolipidemic preparations (simvastatin and fenofibrate). Both preparations changed phospholipid composition of high-density lipoproteins and improved their functional activity. The differences in the phospholipid composition of high-density lipoproteins were probably related to lipolysis of triglyceride-rich lipoproteins catalyzed by lipoprotein lipase and, in particular, hepatic lipase.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Anticholesteremic Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Cardiolipins,
http://linkedlifedata.com/resource/pubmed/chemical/Cholesterol,
http://linkedlifedata.com/resource/pubmed/chemical/Cholesterol, HDL,
http://linkedlifedata.com/resource/pubmed/chemical/Fenofibrate,
http://linkedlifedata.com/resource/pubmed/chemical/HDL-triglyceride,
http://linkedlifedata.com/resource/pubmed/chemical/Hypolipidemic Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Lipoproteins, HDL,
http://linkedlifedata.com/resource/pubmed/chemical/Lysophosphatidylcholines,
http://linkedlifedata.com/resource/pubmed/chemical/Phosphatidylcholines,
http://linkedlifedata.com/resource/pubmed/chemical/Phosphatidylethanolamines,
http://linkedlifedata.com/resource/pubmed/chemical/Phospholipids,
http://linkedlifedata.com/resource/pubmed/chemical/Simvastatin,
http://linkedlifedata.com/resource/pubmed/chemical/Sphingomyelins,
http://linkedlifedata.com/resource/pubmed/chemical/Triglycerides,
http://linkedlifedata.com/resource/pubmed/chemical/high density lipoprotein...
|
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
0007-4888
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
131
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
321-4
|
pubmed:dateRevised |
2010-11-18
|
pubmed:meshHeading |
pubmed-meshheading:11550015-Adult,
pubmed-meshheading:11550015-Anticholesteremic Agents,
pubmed-meshheading:11550015-Cardiolipins,
pubmed-meshheading:11550015-Cholesterol,
pubmed-meshheading:11550015-Cholesterol, HDL,
pubmed-meshheading:11550015-Fenofibrate,
pubmed-meshheading:11550015-Humans,
pubmed-meshheading:11550015-Hyperlipidemias,
pubmed-meshheading:11550015-Hypolipidemic Agents,
pubmed-meshheading:11550015-Lipolysis,
pubmed-meshheading:11550015-Lipoproteins, HDL,
pubmed-meshheading:11550015-Lysophosphatidylcholines,
pubmed-meshheading:11550015-Male,
pubmed-meshheading:11550015-Middle Aged,
pubmed-meshheading:11550015-Phosphatidylcholines,
pubmed-meshheading:11550015-Phosphatidylethanolamines,
pubmed-meshheading:11550015-Phospholipids,
pubmed-meshheading:11550015-Simvastatin,
pubmed-meshheading:11550015-Sphingomyelins,
pubmed-meshheading:11550015-Triglycerides
|
pubmed:year |
2001
|
pubmed:articleTitle |
Phospholipid composition of high-density lipoproteins reflects lipolysis of triglyceride-rich lipoproteins during hyperlipidemia.
|
pubmed:affiliation |
Department of Metabolic Disorders, State Research Center of Preventive Medicine, Russian Ministry of Health, Moscow.
|
pubmed:publicationType |
Journal Article
|